C

CL

CL

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
CL Live QuoteReal-time
$96.88
+$3.48(+3.73%)1M
Day Range$95.93 – $97.71
Open$97.35
Previous Close$98.85
Volume6.38M
Key Financials & Valuation
Fundamental balance sheet & market metrics
CONSUMER DEFENSIVE
Market Cap$77.01B
P/E Ratio (TTM)38.4
Forward P/E24.2
EPS (TTM)$2.52
Price to Book272.8
Dividend Yield2.12%
Beta (Volatility)0.31
IndustryHOUSEHOLD & PERSONAL PRODUCTS
52-Week RangeCurrent: $96.88 (82%)
Low: $74.18High: $101.81
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$101.70-32.2% upside

Insider Buys

0

$0

Insider Sales

3

$6.29M

Total Volume

$6.29M

3 transactions

Net Activity

$6.29M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
H
1

Hazlin John

Chief Growth Officer

0 buys1 sells

$2.32M total

W
2

Wallace Noel R.

COB, Pres, CEO

0 buys1 sells

$2.01M total

T
3

Tsourapas Panagiotis

COO, CD, EMEA, APac, Skin

0 buys1 sells

$1.97M total

Trading History
CL insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 5, 2026

2 weeks ago

Wallace Noel R.

COB, Pres, CEO

CEO
Sell20.0K$100.26$2.01M

Nov 4, 2026

2 weeks ago

Tsourapas Panagiotis

COO, CD, EMEA, APac, Skin

COO
Sell19.9K$98.74$1.97M

Nov 4, 2026

2 weeks ago

Hazlin John

Chief Growth Officer

C-Level
Sell23.4K$99.15$2.32M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
CL Buy Conviction0%
Industry Rank#172 of 569
Volume Contribution0.0%
Total Industry Activity$16.53B

CL has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. CL ranks #172 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for CL

Over the last 90 days, corporate insiders at CL (CL) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $6.29M.

The net insider activity for CL shows a net selling bias of $6.29M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Hazlin John (Chief Growth Officer), who traded 23.4K shares valued at $2.32M on Nov 4, 2026.

Live Market News & Developments
Aggregated real-time headlines for CL (CL)
6 updates

Universal Health Services Inc. Cl B stock outperforms competitors despite losses on the day

MarketWatch13h ago

Colgate Palmolive (CL) Stock May Be 21% Below Fair Value Today

Yahoo Finance6d ago

Manchester United PLC-CL A (NYSE:MANU) Slides on Wider Q1 Loss and Revenue Miss

ChartMill21h ago

AMC Entertainment Holdings Inc. Cl A stock underperforms Thursday when compared to competitors

MarketWatch12h ago

Mineros S.A. (MINEROS.CL) Stock Price, News, Quote & History

Yahoo! Finance Canada2d ago

Mondelez International Inc. Cl A stock outperforms competitors despite losses on the day

MarketWatch13h ago

Related News & Analyst Reports

Read original insights and educational research covering CL and the Unknown sector.

August 6, 2026

The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop

An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.

Read Analysis
August 5, 2026

The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings

An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.

Read Analysis
August 1, 2026

The Quant Guide: Backtesting SEC Form 4 Cluster Buys for Alpha

A rigorous quantitative backtest of SEC Form 4 cluster buying activity, demonstrating how to isolate signal from noise and build portfolios that consistently outperform benchmarks.

Read Analysis
June 18, 2026

The Impact of Interest Rates on Insider Behavior: A Macro Analysis

When the Fed tightens, equity valuations fall, but insider purchase activity does not always follow the same pattern. This report examines three rate-hike cycles to show how rising rates affect the frequency and conviction of C-suite stock buys.

Read Analysis
May 14, 2026

Spotting Insider Sells: When to Worry and When to Ignore

Most insider sales are irrelevant, estate planning, tax obligations, diversification. But certain Form 4 selling patterns are genuine red flags. This guide teaches you exactly when to worry: cluster sells, CEO departures, and pre-restatement patterns.

Read Analysis
March 12, 2026

Unusual Insider Buying Patterns: Spotting the Anomalies

Beyond simple purchase screens, unusual insider buying patterns, accelerating purchase velocity, off-hours filings, purchases during active 10b5-1 plans, can reveal extraordinary conviction. This guide documents nine pattern types and their historical signal accuracy.

Read Analysis

FAQs About CL Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for CL.

Based on SEC Form 4 disclosures, the Insider Confidence Score for CL is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 3 sales by company executives over the last 90 days.

The CEO Conviction Index for CL is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.